KEARNY, NJ (March 29, 2007) -- Proprietary Nutritionals Inc. (PNI) has announced that a research study conducted with Celadrin®, a proprietary blend of special fatty acids lauded for its ability to promote joint health, demonstrated that Celadrin can significantly increase walking ability and decrease knee discomfort.
The double-blind, placebo-controlled study, was commissioned by its developer, Imagenetix, Inc., and conducted by Jay Udani, M.D., Medical Director of Medicus Research, and Director of the Integrative Medicine Program at Northridge Hospital. It is the fourth clinical study performed on the efficacy of Celadrin in the past six years.
The study reported that after eight weeks of taking Celadrin capsules, average walking ability increased 45 percent, and participants claimed a 35 percent decrease in knee discomfort. These improvements were significantly better than the results seen in the placebo group, and no negative side effects were found throughout the entire study.
“This study demonstrates that after two weeks of taking Celadrin orally, subjects showed significant enhancement of their functional ability with progressive improvement continuing through the end of the eight week study,” said Dr. Udani.
The randomized study, evaluated 93 participants over a period of 60 days. Subjects, ranging from 40 to 86 years of age, were evaluated before Celadrin was administered and again after two, four and eight weeks. During each evaluation, participants were asked to walk for six minutes to measure how far they could travel with their knee discomfort.
The participants who consumed Celadrin were able to walk an average distance of 1183 feet when they started the study. After only two weeks of taking Celadrin capsules, the average walking distance increased significantly by about 19 percent, or approximately 232 feet. The participants continued to improve throughout the study period and after eight weeks of taking Celadrin capsules; the participants walked an average distance of 1720 feet—45 percent more than when they had started only two months before.
A previous study on the efficacy of Celadrin-based cream published in the Journal of Rheumatology in 2004, states that patients reported significant relief in joint pain after only 30 minutes of application – benefits which continued to improve over time with daily use of the product.
Proprietary Nutritionals, Inc., a subsidiary of Pharmachem Laboratories, Inc., is located in Kearny, NJ. PNI markets Celadrin® Joint Flexibility & Relief, and other patented, scientifically proven, branded ingredients to the nutraceuticals industry. For further information, visit www.celadrin.com or call 519/647-2071.